loading page

How we approach coagulopathy with vascular anomalies.
  • Joana Mack,
  • Shelley Crary
Joana Mack
Arkansas Children's Hospital

Corresponding Author:jmmack@uams.edu

Author Profile
Shelley Crary
University of Arkansas for Medical Sciences
Author Profile


Some vascular anomalies can present with challenging hematologic aberrations. Kaposiform hemangioendothelioma (KHE) may be complicated with Kasabach-Merritt phenomenon (KMP) and stagnant blood flow in slow flow malformations can promote activation and consumption of coagulation factors which results in bleeding and clotting known as localized intravascular coagulopathy (LIC). These patients can experience significant morbidity secondary to pain due to thrombosis and are at higher risk of hematologic complications during surgical procedures. No standard of care has been established to prevent or manage these complications. This review focuses on the management of coagulopathy in children and adults with vascular anomalies.
07 Apr 2021Submitted to Pediatric Blood & Cancer
07 Apr 2021Submission Checks Completed
07 Apr 2021Assigned to Editor
08 Apr 2021Reviewer(s) Assigned
12 May 2021Review(s) Completed, Editorial Evaluation Pending
12 May 2021Editorial Decision: Revise Minor
14 Aug 20211st Revision Received
14 Aug 2021Submission Checks Completed
14 Aug 2021Assigned to Editor
15 Aug 2021Reviewer(s) Assigned
31 Aug 2021Review(s) Completed, Editorial Evaluation Pending
31 Aug 2021Editorial Decision: Accept
Aug 2022Published in Pediatric Blood & Cancer volume 69 issue S3. 10.1002/pbc.29353